Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for ICON PLC (ICLR : NSDQ)

• Company Description    ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. Number of Employees: 41,900

• Price / Volume Information    Yesterday's Closing Price: $182.22 Daily Weekly Monthly 20 Day Moving Average: 671,439 shares Shares Outstanding: 80.76 (millions) Market Capitalization: $14,715.52 (millions) Beta: 1.26 52 Week High: $228.29 52 Week Low: $125.10 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -1.91% -1.74% 12 Week -2.92% -4.49% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL SOUTH COUNTY BUSINESS PARK LEOPARDSTOWN - DUBLIN 18,L2 00000 IRL ph: 353-1291-2000 fax: 353-1247-6260 None http://www.iconplc.com

• General Corporate Information    Officers Steve Cutler - Chief Executive Officer and Director Ciaran Murray - Chair and Director Barry Balfe - Chief Operating Officer Nigel Clerkin - Chief Financial Officer Ronan Murphy - Lead Independent Director Peer Information ICON PLC (CHCR) ICON PLC (ESRX) ICON PLC (MYDP) ICON PLC (COR) ICON PLC (GBCS) ICON PLC (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: G4705A100 SIC: 8731 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 02/18/26 Share - Related Items Shares Outstanding: 80.76 Most Recent Split Date: 8.00 (2.00:1) Beta: 1.26 Market Capitalization: $14,715.52 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $2.99 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $12.64 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 6.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: 4.32% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 02/18/26

• Fundamental Ratios P/E Current FY Estimate: 14.42 Trailing 12 Months: 14.60 PEG Ratio: 3.34 Price Ratios Price/Book: 1.58 Price/Cash Flow: 9.09 Price / Sales: 1.82 EPS Growth vs. Year Ago Period: -12.11% vs. Previous Quarter: -10.44% Sales Growth vs. Year Ago Period: 0.63% vs. Previous Quarter: 1.26% ROE 12/31/25 - - 09/30/25 - 10.58 06/30/25 - 10.95 ROA 12/31/25 - - 09/30/25 - 6.01 06/30/25 - 6.23 Current Ratio 12/31/25 - - 09/30/25 - 1.06 06/30/25 - 1.29 Quick Ratio 12/31/25 - - 09/30/25 - 1.06 06/30/25 - 1.29 Operating Margin 12/31/25 - - 09/30/25 - 12.38 06/30/25 - 12.98 Net Margin 12/31/25 - - 09/30/25 - 7.40 06/30/25 - 9.82 Pre-Tax Margin 12/31/25 - - 09/30/25 - 7.67 06/30/25 - 10.11 Book Value 12/31/25 - - 09/30/25 - 115.59 06/30/25 - 118.32 Inventory Turnover 12/31/25 - - 09/30/25 - - 06/30/25 - - Debt-to-Equity 12/31/25 - - 09/30/25 - 0.31 06/30/25 - 0.35 Debt-to-Capital 12/31/25 - - 09/30/25 - 23.57 06/30/25 - 26.16

Powered by Zacks Investment Research ©